BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17089619)

  • 1. Clofazimine induced enteropathy--a case highlighting the importance of drug induced disease in differential diagnosis.
    Mathew BS; Pulimood AB; Prasanna CG; Ramakrishna BS; Chandy SJ
    Trop Gastroenterol; 2006; 27(2):87-8. PubMed ID: 17089619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Persistent type 2 lepra reaction (erythema nodosum) and clofazimine-induced lethal enteropathy].
    Rodríguez G; Pinto R; López F; Gómez Y
    Biomedica; 2009 Mar; 29(1):18-24. PubMed ID: 19753835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An unusual cause of small-intestine mucosal pigmentation.
    Raftopoulos SC; Fermoyle S
    Gastrointest Endosc; 2011 Jun; 73(6):1285-6. PubMed ID: 21354567
    [No Abstract]   [Full Text] [Related]  

  • 4. Intra-abdominal, crystal-storing histiocytosis due to clofazimine in a patient with lepromatous leprosy and concurrent carcinoma of the colon.
    Pais AV; Pereira S; Garg I; Stephen J; Antony M; Inchara YK
    Lepr Rev; 2004 Jun; 75(2):171-6. PubMed ID: 15282969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clofazimine enteropathy in a pediatric bone marrow transplant recipient.
    Parizhskaya M; Youssef NN; Di Lorenzo C; Goyal RK
    J Pediatr; 2001 Apr; 138(4):574-6. PubMed ID: 11295724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy.
    Goulart IM; Reis AC; De Rezende TM; Borges AS; Ferreira MS; Nishioka SA
    Lepr Rev; 2005 Jun; 76(2):167-9. PubMed ID: 16038251
    [No Abstract]   [Full Text] [Related]  

  • 7. [Small intestine transit anomalies in a patient with chronic abdominal pain and treated for Hansen's disease].
    Davy C; Riveau E; Bousquet JC; Curet P; Vayre P; Cortez A; Grellet J
    J Radiol; 1986 Mar; 67(3):213-8. PubMed ID: 3528476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photosensitisation induced by clofazimine in a cat.
    Bennett Sl
    Aust Vet J; 2007 Sep; 85(9):375-80. PubMed ID: 17760943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clofazimine-induced enteropathy in a patient of leprosy.
    Singh H; Azad K; Kaur K
    Indian J Pharmacol; 2013; 45(2):197-8. PubMed ID: 23716903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clofazimine-induced crystal-storing histiocytosis producing chronic abdominal pain in a leprosy patient.
    Sukpanichnant S; Hargrove NS; Kachintorn U; Manatsathit S; Chanchairujira T; Siritanaratkul N; Akaraviputh T; Thakerngpol K
    Am J Surg Pathol; 2000 Jan; 24(1):129-35. PubMed ID: 10632497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case Report: Borderline Lepromatous Leprosy Therapy Complicated by Type 1 Leprosy Reaction and Adverse Reactions with Dapsone and Clofazimine.
    Matono T; Suzuki S; Mori S; Ato M
    Am J Trop Med Hyg; 2024 Mar; 110(3):483-486. PubMed ID: 38266303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excretion of clofazimine in human milk in leprosy patients.
    Venkatesan K; Mathur A; Girdhar A; Girdhar BK
    Lepr Rev; 1997 Sep; 68(3):242-6. PubMed ID: 9364825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dapsone induced pulmonary eosinophilia without cutaneous allergic manifestations--an unusual encounter--a case report.
    Arunthathi S; Raju S
    Acta Leprol; 1998; 11(1):3-5. PubMed ID: 9693685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dapsone induced eosinophilic pneumonia.
    Adar T; Tayer-Shifman O; Mizrahi M; Tavdi S; Barak O; Shalit M
    Eur Ann Allergy Clin Immunol; 2012 Jun; 44(3):144-6. PubMed ID: 22905598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue concentration, systemic distribution and toxicity of clofazimine--an autopsy study.
    Jadhav MV; Sathe AG; Deore SS; Patil PG; Joshi NG
    Indian J Pathol Microbiol; 2004 Apr; 47(2):281-3. PubMed ID: 16295502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lepromatous leprosy with drug reaction.
    Baxt RD
    Dermatol Online J; 2000 Sep; 6(1):9. PubMed ID: 11328619
    [No Abstract]   [Full Text] [Related]  

  • 17. Borderline lepromatous leprosy presenting as a single cutaneous plaque.
    Armour KS; Scolyer RA; Barnetson RS
    Australas J Dermatol; 2005 Aug; 46(3):181-3. PubMed ID: 16008652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clofazimine induced nail changes.
    Dixit VB; Chaudhary SD; Jain VK
    Indian J Lepr; 1989 Oct; 61(4):476-8. PubMed ID: 2621382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphangiographic evaluation of patients with clinical lepromatous leprosy on clofazimine.
    Oommen ST; Natu MV; Mahajan MK; Kadyan RS
    Int J Lepr Other Mycobact Dis; 1994 Mar; 62(1):32-6. PubMed ID: 8189086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse effects from multi-drug therapy in leprosy: a Brazilian study.
    Deps PD; Nasser S; Guerra P; Simon M; Birshner Rde C; Rodrigues LC
    Lepr Rev; 2007 Sep; 78(3):216-22. PubMed ID: 18035772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.